Research Topics
Genomes and GenesSpecies | Paul E KeckSummaryAffiliation: University of Cincinnati Country: USA Publications
| Collaborators
|
Detail Information
Publications
Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar maniaPaul E Keck
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
J Clin Psychiatry 70:844-51. 2009..To evaluate long-term safety and efficacy of ziprasidone...- Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenonTrisha Suppes
Bipolar Disorder Research Program, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas 75390 9121, USA
Arch Gen Psychiatry 62:1089-96. 2005..The prevalence of depressive symptoms co-occurring with hypomanic symptoms has not been quantified. Whether there is a greater likelihood for women to experience mixed symptoms has not been resolved... - Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized studyLori L Altshuler
Department of Psychiatry, Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles, CA, USA
J Clin Psychiatry 70:450-7. 2009..To assess long-term outcome in bipolar disorder, subjects were prospectively followed after receiving acute treatment for bipolar depression... - Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trialSusan L McElroy
Psychopharmacology Research Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
J Affect Disord 101:275-81. 2007..Increasing evidence indicates that some second-generation antipsychotics are efficacious in bipolar depression, but there are few data on this illness for the novel agent aripiprazole... - A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disordersSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
Bipolar Disord 9:426-34. 2007..The objective of this study was to compare sibutramine and topiramate as adjunctive treatments for psychotropic-associated weight gain in overweight or obese outpatients with BD... - Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trialSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, PO Box 670559, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
J Clin Psychiatry 66:617-24. 2005..The response of 62 outpatients with DSM-IV bipolar disorders to open-label adjunctive zonisamide was evaluated in a prospective 8-week acute trial, followed by a 48-week continuation trial, conducted from June 2001 through May 2002... - Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placeboPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 68:1480-91. 2007..Efficacy and tolerability of aripiprazole for relapse prevention in bipolar I disorder was, therefore, evaluated for 100 weeks... - Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment NetworkTrisha Suppes
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9121, USA
Int Clin Psychopharmacol 22:376-81. 2007..No between-group differences in improvement were found. Adjunctive quetiapine may be useful as continuation treatment in bipolar populations with both pure depressive and cycling symptoms. Further controlled studies are warranted... - Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite studyLori L Altshuler
Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, CA, USA
J Clin Psychiatry 67:1551-60. 2006..Research examining this relationship in persons with bipolar disorder is rare. This study sought to evaluate the association between subsyndromal depressive symptoms and role functioning in subjects with bipolar disorder... - Ethnicity and first-rank symptoms in patients with psychosisLesley M Arnold
Bipolar and Psychotic Disorders Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
Schizophr Res 67:207-12. 2004..These findings indicate that psychotic symptom presentation should be evaluated in the context of other symptoms (e.g., affective symptoms) in diagnostic assessments in order to prevent misdiagnoses of schizophrenia... - Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for maniaStephen M Strakowski
Division of Bipolar Disorders Research, University of Cincinnati College of Medicine, 231 Albert Sabin Way ML0559, PO Box 670559, Cincinnati, OH 45267 0559, USA
Arch Gen Psychiatry 62:851-8. 2005..Alcohol-use disorders are common co-occurring conditions affecting bipolar patients, and this co-occurrence is negatively associated with outcome... - Topiramate in the long-term treatment of binge-eating disorder associated with obesitySusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 65:1463-9. 2004..This study assessed the long-term effectiveness and tolerability of topiramate in binge-eating disorder (BED) with obesity... - Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illnessPaul E Keck
Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267-0559, USA
Compr Psychiatry 44:263-9. 2003..The lack of observable prognostic impact may have been, in part, due to the relatively high morbidity and poor functional outcome of a substantial portion of the total cohort... - Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for maniaStephen M Strakowski
Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, 2341 Albert Sabin Way, Cincinnati, OH 45267, USA
Arch Gen Psychiatry 64:57-64. 2007..Cannabis use disorders commonly co-occur in bipolar disorder; however, the effects of cannabis abuse on outcome have been minimally studied... 
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depressionMark A Frye
Department of Psychiatry, Mayo Mood Clinic and Research Program, Mayo Clinic, 200 First St, S W, Rochester, MN 55901, USA
Am J Psychiatry 166:164-72. 2009..This study examined the correlates associated with treatment-emergent mania in patients receiving adjunctive antidepressant treatment for bipolar depression...
Characterizing impulsivity in maniaStephen M Strakowski
Division of Bipolar Disorders Research, Universtiy of Cincinnati College of Medicine, Cincinnati, OH, USA
Bipolar Disord 11:41-51. 2009....- The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar maniaPaul E Keck
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
J Clin Psychiatry 66:5-11. 2005..Therefore, selecting a second-generation antipsychotic requires consideration of how an agent's efficacy, onset of action, and adverse events profile influence its appropriateness for each patient... - Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorderCaroline M Nievergelt
Department of Psychiatry, University of California, San Diego, La Jolla, California 92093 0603, USA
Am J Med Genet B Neuropsychiatr Genet 141:234-41. 2006..However, the trends for ARNTL and PER3 are suggestive of their involvement in bipolar disorder and warrant further study in a larger sample... - Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine and the Mental Health Care Line, Cincinnati, Ohio 45267 0559, USA
Biol Psychiatry 60:1020-2. 2006..The results of pilot trials suggest that omega-3 fatty acids may have efficacy in the treatment of mood symptoms in bipolar disorder... - Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trialAnna I Guerdjikova
Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
Int Clin Psychopharmacol 24:150-8. 2009..As a result of an exceptionally high placebo response, it is likely that for efficacy measures except for body weight and metabolic indices, the study was incapable of detecting potentially clinically important drug-placebo difference... - Comorbidity of fibromyalgia and psychiatric disordersLesley M Arnold
Women s Health Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, USA
J Clin Psychiatry 67:1219-25. 2006..To assess the co-occurrence of fibromyalgia with psychiatric disorders in participants of a fibromyalgia family study... - Treatment costs and health care utilization for patients with bipolar disorder in a large managed care populationJeff J Guo
College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH, USA
Value Health 11:416-23. 2008.... - Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trialSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
J Clin Psychiatry 67:1897-906. 2006..Binge eating disorder (BED) is associated with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to evaluate zonisa-mide in the treatment of BED associated with obesity... - Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorderJeff J Guo
Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy and the Institute for the Study of Health, University of Cincinnati Academic Health Center, 3225 Eden Avenue, Cincinnati, OH 45267 0004, USA
Psychiatr Serv 58:1073-8. 2007..This study assessed costs among patients with bipolar disorder for treatment related to bipolar disorder and to comorbid conditions. Risk factors associated with costs were also assessed... - Are mood disorders and obesity related? A review for the mental health professionalSusan L McElroy
Psychopharmacology Research and Eating Disorders and Obesity Research and Treatment Programs, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 65:634-51, quiz 730. 2004..We reviewed evidence regarding a possible relationship between mood disorders and obesity to better inform mental health professionals about their overlap... - Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trialPaul E Keck
Department of Psychiatry, University of Cincinnati College of Medicine, OH 45627 0559, USA
Am J Psychiatry 160:741-8. 2003..The study evaluated the efficacy and tolerability of ziprasidone, compared with placebo, in the treatment of adult patients with acute bipolar mania... - Citalopram in the treatment of binge-eating disorder: a placebo-controlled trialSusan L McElroy
Division of Psychopharmacology Research and Eating Disorders, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 64:807-13. 2003..Citalopram is a highly selective serotonin reuptake inhibitor antidepressant. The purpose of this study was to assess the efficacy and safety of citalopram in the treatment of binge-eating disorder... - Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depressionPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 66:611-6. 2005..These subanalyses compare treatment-emergent mania rates in bipolar I depressed patients treated with olanzapine, placebo, or olanzapine/fluoxetine combination... - Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?Susan L McElroy
Psychopharmacology Research Program, University of Cincinnati College of Medicine, P O Box 670559, 231 Bethesda Avenue, Cincinnati, OH 45267 0559, USA
J Affect Disord 86:107-27. 2005..The co-occurrence of bipolar and eating disorders, though of major clinical and public health importance, remains relatively unexamined... - Further evidence for linkage of bipolar disorder to chromosomes 6 and 17 in a new independent pedigree seriesTiffany A Greenwood
Department of Psychiatry, University of California, San Diego, CA, USA
Bipolar Disord 14:71-9. 2012..We now report the results of our genome-wide linkage analysis in an independent sample of 34 pedigrees segregating bipolar disorder... - Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control studyJeff J Guo
College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0004, USA
Pharmacotherapy 27:27-35. 2007..To quantify the risk of diabetes mellitus associated with atypical antipsychotics compared with conventional antipsychotics in managed care Medicaid patients with bipolar disorder... - Defining and improving response to treatment in patients with bipolar disorderPaul E Keck
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 65:25-9. 2004..Psychoeducation for patients and families and interpersonal psychotherapy also can help prolong remission... - Factors associated with medication adherence in African American and white patients with bipolar disorderDavid E Fleck
Center for Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
J Clin Psychiatry 66:646-52. 2005..The purpose of this study was to examine rates of medication nonadherence, self-perceived reasons for nonadherence, and attitudes associated with non-adherence in these ethnic groups... - Incidence of childhood-onset bipolar illness in the USA and EuropeRobert M Post
Department of Psychiatry, George Washington University, Washington, DC, USA
Br J Psychiatry 192:150-1. 2008..In the USA there was also twice the incidence of childhood adversity and genetic/familial risk for affective disorder. The findings deserve replication and further exploration... - Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesityRenu Kotwal
Department of Psychiatry, Psychopharmacology Research Program, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
Hum Psychopharmacol 21:425-31. 2006..To evaluate the effectiveness of lithium augmentation of topiramate on mood symptoms, binge eating behavior, and body weight in obese bipolar patients with binge eating disorder (BED) seeking weight management... - A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorderPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
J Clin Psychiatry 67:626-37. 2006..To investigate the safety and efficacy of aripiprazole in preventing relapse of a mood episode in recently manic- or mixed-episode patients with bipolar I disorder stabilized on aripiprazole... - Pharmacologic treatment considerations in co-occurring bipolar and anxiety disordersPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
J Clin Psychiatry 67:8-15. 2006..Anxiety disorders are among the most commonly co-occurring psychiatric syndromes with bipolar disorder. The presence of co-occurring anxiety disorders has important prognostic and treatment implications... - Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trialSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
J Clin Psychiatry 68:390-8. 2007..Binge-eating disorder (BED) is associated with obesity. Atomoxetine is a highly selective norepinephrine reuptake inhibitor associated with weight loss. The purpose of this study was to evaluate atomoxetine in the treatment of BED... - Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorderSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
J Affect Disord 107:127-33. 2008..No published studies have statistically evaluated the relationship between the outcomes in maintenance treatment and the principal acute agent... - New approaches in managing bipolar depressionPaul E Keck
Program Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 64:13-8. 2003.... - Maintenance efficacy of divalproex in the prevention of bipolar depressionLaszlo Gyulai
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
Neuropsychopharmacology 28:1374-82. 2003.... - Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialSusan L McElroy
Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
Am J Psychiatry 160:255-61. 2003..Binge eating disorder is associated with obesity. Topiramate is an antiepileptic agent associated with weight loss. The objective of this study was to evaluate topiramate in the treatment of binge eating disorder associated with obesity... - High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trialAnna I Guerdjikova
Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
Hum Psychopharmacol 23:1-11. 2008..The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity... - A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are neededDrew H Barzman
Children s Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati, Ohio 45229 3039, USA
J Child Adolesc Psychopharmacol 17:503-9. 2007..Our secondary objective was to examine demographic and clinical factors associated with treatment response... - Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder familiesLynn M Evans
Department of Psychiatry, Columbia University, New York, New York, USA
Am J Med Genet B Neuropsychiatr Genet 147:326-32. 2008..The temperament-based cyclothymic trait yielded a higher peak LOD score and a lower P-value than analyses using traditional, categorical phenotypes in a separate analysis including these same families... - Comorbidity of eating disorders with bipolar disorder and treatment implicationsSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
Bipolar Disord 8:686-95. 2006..To review the scientific evidence examining the comorbidity among eating disorders and bipolar disorder (BD)... - Long-term therapy of bipolar illnessPaul E Keck
University of Cincinnati College of Medicine, USA
J Fam Pract . 2003 - Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight managementAnna I Guerdjikova
Psychopharmacology Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0559, USA
Eat Behav 8:266-76. 2007..Early recognition and attention to eating and mood dysregulation, including, but not limited to binge eating disorder and bulimia nervosa, in some persons, might help reduce their lifetime risk for obesity... - Examination of the clock gene Cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or associationCaroline M Nievergelt
Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093, USA
Psychiatr Genet 15:45-52. 2005..Additional, more powerful, studies involving Cry1 and other circadian clock genes need to be tested before an association of circadian abnormalities with bipolar disorder can be excluded... - Are bipolar mood symptoms affected by the phase of the menstrual cycle?Geetha Shivakumar
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9086, USA
J Womens Health (Larchmt) 17:473-8. 2008..We sought to examine the relationship between bipolar disorder and menstrual cycle-related mood changes. To our knowledge, this is one of the largest samples in the literature addressing this issue... - Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trialSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 69:433-40. 2008..Olanzapine is a second-generation antipsychotic with mood-stabilizing properties and antagonistic activity at several dopamine receptors. The purpose of this study was to evaluate olanzapine in the treatment of pathological gambling... - Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trialSusan L McElroy
Division of Clinical Neuroscience, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 65:50-6. 2004..It commonly co-occurs with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to preliminarily assess zonisamide in the treatment of binge-eating disorder... - Suggestive evidence for linkage of ADHD features in bipolar disorder to chromosome 10p14Eun Jeong Joo
Department of Psychiatry, University of California, San Diego, La Jolla, California, USA
Am J Med Genet B Neuropsychiatr Genet 153:260-8. 2010..10p14, in particular may contain a locus for inattention in bipolar disorder. Quantitative dimensional phenotypes such as this may be useful for both mapping of genes and understanding the role of genes in bipolar disorder... - Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorderNick C Patel
Department of Psychiatry, University of Cincinnati, and the General Clinical Research Center and Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Ohio 45267 0004, USA
J Child Adolesc Psychopharmacol 15:938-46. 2005..The aim of this study was to compare the longitudinal use of psychotropic medications in African-American and Caucasian adolescents with a diagnosis of bipolar disorder following their first psychiatric hospitalization... - Phenomenology associated with age at onset in patients with bipolar disorder at their first psychiatric hospitalizationNick C Patel
College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267 0004, USA
Bipolar Disord 8:91-4. 2006..To compare the clinical presentation of patients with early-onset (age <18 years) and typical-onset (age 20-30 years) bipolar disorder at the time of first hospitalization... - Long-term management strategies to achieve optimal function in patients with bipolar disorderPaul E Keck
Department of Psychiatry, University of Cincinnati College of Medicine, and the General Clinical Research Center and Mental Health Care Line, Cincinnati Veterans Affairs Medical Center, Ohio 45267 0559, USA
J Clin Psychiatry 67:19-24; discussion 36-42. 2006..Substantial information is needed regarding the prevalence and causes of cognitive dysfunction in bipolar disorder, the effects of existing treatments on cognition, and long-term treatments to improve cognition and functioning... - Familiality of temperament in bipolar disorder: support for a genetic spectrumLynn Evans
Department of Psychiatry, UCSD, School of Medicine, University of California, 9500 Gilman Drive, La Jolla, CA 92093-0603, USA
J Affect Disord 85:153-68. 2005..Nevertheless, both of these scales may be useful quantitative traits for genetic mapping studies... - Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorderTiffany A Greenwood
Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, USA
Am J Med Genet B Neuropsychiatr Genet 162:137-45. 2013..002, 0.007, and 8 × 10(-4), respectively). These data suggest that variants within DAT1 may predispose to a subtype of BD characterized by early prodromal features that include attentional deficits... - Predictors of response to treatment of acute bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trialsJeffrey A Welge
Division of Clinical Neuroscience, Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA
J Clin Psychopharmacol 24:607-12. 2004..Stratification on the basis of these prognostic factors may improve the power of future trials for the treatment of acute mania and may help explain patient response to treatment... - Reproductive function and risk for PCOS in women treated for bipolar disorderNatalie L Rasgon
Department of Psychiatry, Stanford School of Medicine, Palo Alto, CA, USA
Bipolar Disord 7:246-59. 2005..This study examined the reproductive function and prevalence of polycystic ovary syndrome (PCOS) in women with bipolar disorder taking antimanic medications... - A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar maniaPaul E Keck
Biological Psychiatry Program, Department of Psychiatry, University of Cincinnati College of Medicine, PO Box 670559, Cincinnati, OH 45267 0559, USA
Am J Psychiatry 160:1651-8. 2003..The authors compared the efficacy and safety of aripiprazole, a novel antipsychotic, to placebo for treatment of patients in an acute manic or mixed episode of bipolar disorder... - The Texas implementation of medication algorithms update for treatment of bipolar I disorderRoy H Perlis
Bipolar Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Mass. 02114, USA
J Clin Psychiatry 66:818-20. 2005 - Emotional eating and emotional eating alternatives in subjects undergoing bariatric surgeryAnna I Guerdjikova
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0559, USA
Obes Surg 17:1091-6. 2007..The purpose of this study was to characterize emotional eating and its alternatives in obese patients undergoing bariatric surgery... - Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trialLesley M Arnold
University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, and Newton Wellesley Hospital, Newton, MA, USA
Arthritis Rheum 56:1336-44. 2007..To assess the efficacy and safety of gabapentin in patients with fibromyalgia...